Circulating retinol-binding protein 4 levels in gestational diabetes mellitus: A meta-analysis of observational studies

Gynecological Endocrinology

Volumn 31, Issue 5, 2015, Pages 337-344

  Huang, Qi Tao ^a,b   Huang, Qiong ^a   Luo, Wei ^a   Li, Fei ^a   Hang, Li Lin ^a   Yu, Yan Hong ^a   Zhong, Mei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Diabetes; Gestational diabetes mellitus; Insulin resistance; Pregnancy; Retinol binding protein 4

Indexed keywords

RETINOL BINDING PROTEIN 4; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ARTICLE; ASIAN; BODY MASS; CASE CONTROL STUDY; COHORT ANALYSIS; CORRELATION ANALYSIS; EMBASE; GLUCOSE BLOOD LEVEL; HUMAN; MATERNAL AGE; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SECOND TRIMESTER PREGNANCY; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY; WEB OF SCIENCE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CAUCASIAN; FEMALE; METABOLISM; PREGNANCY;

ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES, GESTATIONAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RETINOL-BINDING PROTEINS, PLASMA;

EID: 84931388823     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2015.1005594     Document Type: Article

References (57)

1. DeSisto CL, Kim SY, Sharma AJ. Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010. Prev Chronic Dis 2014;11:E104.
2. Yew TW, Khoo CM, Thai AC, et al. The prevalence of gestational diabetes mellitus among asian women is lower using the new 2013 World Health Organization Diagnostic Criteria. Endocr Pract 2014; 16:1-20.
3. Benhalima K, Hanssens M, Devlieger R, et al. Analysis of pregnancy outcomes using the new IADPSG Recommendation Compared with the Carpenter and Coustan Criteria in an area with a low prevalence of gestational diabetes. Int J Endocrinol 2013;2013: 248121.
4. Montoro MN, Kjos SL, Chandler M, et al. Insulin resistance and preeclampsia in gestational diabetes mellitus. Diabetes Care 2005; 28:1995-2000.
5. Endo S, Maeda K, Suto M, et al. Differences in insulin sensitivity in pregnant women with overweight and gestational diabetes mellitus. Gynecol Endocrinol 2006;22:343-9.
6. Toulis KA, Goulis DG, Kolibianakis EM, et al. Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Fertil Steril 2009;92:667-77.
7. Colagiuri S, Falavigna M, Agarwal MM, et al. Strategies for implementing the WHO diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Diabetes Res Clin Pract 2014;103:364-72.
8. Mutsaerts MA, Groen H, Buiter-Van der Meer A, et al. Effects of paternal and maternal lifestyle factors on pregnancy complications and perinatal outcome. A population-based birth-cohort study: the GECKO Drenthe cohort. Hum Reprod 2014;29:824-34.
9. Carpenter MW. Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care 2007;30:S246-50.
10. Verier-Mine O. Outcomes in women with a history of gestational diabetes. Screening and prevention of type 2 diabetes: literature review. Diabetes Metab 2010;36:595-616.
11. Ng TW, Watts GF, Barrett PH, et al. Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels. Diabetes Care 2007;30:2945-50.
12. Lim S, Choi SH, Jeong IK, et al. Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women. J Clin Endocrinol Metab 2008; 93:2263-8.
13. Ost A, Danielsson A, Lidén M, et al. Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes. FASEB J 2007;21:3696-704.
14. Reinehr T, Stoffel-Wagner B, Roth CL. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J Clin Endocrinol Metab 2008;93:2287-93.
15. Yildizhan R, Ilhan GA, Yildizhan B, et al. Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome. Fertil Steril 2011;96:246-50.
16. Kim SH, Choi HJ, Im JA. Retinol-binding protein 4 responses during an oral glucose tolerance testing in women with gestational diabetes mellitus. Clin Chim Acta 2008;391:123-5.
17. Lewandowski KC, Stojanovic N, Bienkiewicz M, et al. Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1). Gynecol Endocrinol 2008;24: 300-5.
18. Tepper BJ, Kim YK, Shete V, Shabrova E, Quadro L. Serum retinolbinding protein 4 (RBP4) and retinol in a cohort of borderline obese women with and without gestational diabetes. Clin Biochem 2010; 43:320-3.
19. Chan TF, Chen HS, Chen YC, et al. Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus. Reprod Sci 2007;14:169-74.
20. Zhaoxia L, Mengkai D, Qin F, Danqing C. Significance of RBP4 in patients with gestational diabetes mellitus: a case-control study of Han Chinese women. Gynecol Endocrinol 2014;30:161-4.
21. Krzyzanowska K, Zemany L, Krugluger W, et al. Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia 2008;51:1115-22.
22. Klein K, Bancher-Todesca D, Leipold H, et al. Retinol-binding protein 4 in patients with gestational diabetes mellitus. J Womens Health (Larchmt) 2010;19:517-21.
23. Su YX, Hong J, Yan Q, et al. Increased serum retinol-binding protein-4 levels in pregnant women with and without gestational diabetes mellitus. Diabetes Metab 2010;36:470-5.
24. Saucedo R, Zarate A, Basurto L, et al. Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes. Arch Med Res 2011; 42:318-23.
25. Kuzmicki M, Telejko B, Wawrusiewicz-Kurylonek N, et al. Retinolbinding protein 4 in adipose and placental tissue of women with gestational diabetes. Gynecol Endocrinol 2011;27:1065-9.
26. Maghbooli Z, Hossein-Nezhad A, Mirzaei K, et al. Association between retinol-binding protein 4 concentrations and gestational diabetes mellitus and risk of developing metabolic syndrome after pregnancy. Reprod Sci 2010;17:196-201.
27. Nanda S, Nikoletakis G, Markova D, et al. Maternal serum retinolbinding protein-4 at 11-13 weeks' gestation in normal and pathological pregnancies. Metabolism 2013;62:814-9.
28. Abetew DF, Qiu C, Fida NG, et al. Association of retinol binding protein 4 with risk of gestational diabetes. Diabetes Res Clin Pract 2013;99:48-53.
29. Khovidhunkit W, Pruksakorn P, Plengpanich W, Tharavanij T. Retinol-binding protein 4 is not associated with insulin resistance in pregnancy. Metabolism 2012;61:65-9.
30. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:W65-9425.
31. Wells G, Shea B, O'Connell J, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalysis. [updated 2011]. Available from: http://www.ohri.ca/ programs/clinical-epidemiology/oxford.asp.
32. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
33. Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998;316:61-8.
34. Fruscalzo A, Biasioli A, Londero AP, et al. Retinol binding protein as early marker of fetal growth restriction in first trimester maternal serum. Gynecol Endocrinol 2013;29:323-6.
35. Masuyama H, Inoue S, Hiramatsu Y. Retinol-binding protein 4 and insulin resistance in preeclampsia. Endocr J 2011;58:47-53.
36. Deng W, Zhang Y, Zheng Y, et al. Serum retinol-binding protein 4 levels are elevated but do not contribute to insulin resistance in newly diagnosed Chinese hypertensive patients. Diabetol Metab Syndr 2014;6:72.
37. Sun L, Qi Q, Zong G, et al. Elevated plasma retinol-binding protein 4 is associated with increased risk of type 2 diabetes in middle-aged and elderly Chinese adults. J Nutr 2014;144:722-8.
38. Yan H, Chang X, Xia M, et al. Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with nonalcoholic fatty liver disease: a cross-sectional study. Lipids Health Dis 2013;12:157.
39. Gómez-Ambrosi J, Rodŕguez A, Catalán V, et al. Serum retinolbinding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass. Clin Endocrinol (Oxf) 2008;69: 208-15.
40. Takebayashi K, Suetsugu M, Wakabayashi S, et al. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 2007;92:2712-19.
41. Lucarini N, Gerlini G, Palmarino R, et al. Is there a genetic basis for gestational diabetes? Hum Biol 1994;66:715-23.
42. Kim C. Gestational diabetes mellitus in Korean women: similarities and differences from other racial/ethnic groups. Diabetes Metab J 2014;38:1-12.
43. Kim SY, Sappenfield W, Sharma AJ, et al. Racial/ethnic differences in the prevalence of gestational diabetes mellitus and maternal overweight and obesity, by nativity, Florida, 2004-2007. Obesity (Silver Spring) 2013;21:E33-40.
44. Jia J, Bai J, Liu Y, et al. Association between retinol-binding protein 4 and polycystic ovary syndrome: a meta-analysis. Endocr J 2014;61:995-1002.
45. Toulis KA, Goulis DG, Kolibianakis EM, et al. Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Fertil Steril 2009;92: 667-77.
46. Luft VC, Pereira M, Pankow JS, et al.; ARIC Investigators. Retinol binding protein 4 and incident diabetes-the Atherosclerosis Risk in Communities Study (ARIC Study). Rev Bras Epidemiol 2013;16: 388-97.
47. Friebe D, Neef M, Erbs S, et al. Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children. Int J Pediatr Obes 2011;6:e345-52.
48. Chiba M, Saitoh S, Ohnishi H, et al. Associations of metabolic factors, especially serum retinol-binding protein 4 (RBP4), with blood pressure in Japanese-the Tanno and Sobetsu study. Endocr J 2010;57:811-7.
49. Goodman E, Graham TE, Dolan LM, et al. The relationship of retinol binding protein 4 to changes in insulin resistance and cardiometabolic risk in overweight black adolescents. J Pediatr 2009;154:67-73.
50. Di Cianni G, Volpe L, Lencioni C, et al. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract 2003;62:131-7.
51. Shirazian N, Emdadi R, Mahboubi M, et al. Screening for gestational diabetes: usefulness of clinical risk factors. Arch Gynecol Obstet 2009;280:933-7.
52. Kjos SL, Peters RK, Xiang A, et al. Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 1995;44:586-91.
53. Alkharfy KM, Al-Daghri NM, Vanhoutte PM, et al. Serum retinolbinding protein 4 as a marker for cardiovascular disease in women. PLoS One 2012;7:e48612.
54. Santos-Ayarzagoitia M, Salinas-Martńez AM, Villarreal-Pérez JZ. Gestational diabetes: Validity of ADA and WHO diagnostic criteria using NDDG as the reference test. Diabetes Res Clin Pract 2006;74: 322-8.
55. Graham TE, Wason CJ, Blüher M, Kahn BB. Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia 2007;50:814-23.
56. Hartling L, Dryden DM, Guthrie A, et al. Benefits and harms of treating gestational diabetes mellitus: a systematic review and metaanalysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med 2013;159:123-9.
57. Schneider S, Freerksen N, Röhrig S, et al. Gestational diabetes and preeclampsia-similar risk factor profiles? Early Hum Dev 2012;88: 179-84.